Published in Ann Thorac Surg on April 01, 2005
Simultaneous "hybrid" percutaneous coronary intervention and minimally invasive surgical bypass grafting: feasibility, safety, and clinical outcomes. Am Heart J (2008) 0.88
Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery. Eur Heart J (2014) 0.82
Emergency cardiac surgery in patients with acute coronary syndromes: a review of the evidence and perioperative implications of medical and mechanical therapeutics. Anesth Analg (2011) 0.76
Variation in Practice Regarding Pretreatment With Dual Antiplatelet Therapy for Patients With Non-ST Elevation Myocardial Infarction. J Am Heart Assoc (2016) 0.75
Predicting Likelihood for Coronary Artery Bypass Grafting After Non-ST-Elevation Myocardial Infarction: Finding the Best Prediction Model. Ann Thorac Surg (2016) 0.75
Perioperative management of patient with intracoronary stent presenting for noncardiac surgery. Ann Card Anaesth (2016) 0.75
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med (2007) 6.76
Liberal or restrictive transfusion after cardiac surgery. N Engl J Med (2015) 6.69
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood (2011) 6.50
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood (2005) 6.07
Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation (2007) 5.31
Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial. Ophthalmology (2012) 4.70
Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial. Lancet (2013) 4.35
Control chart methods for monitoring cardiac surgical performance and their interpretation. J Thorac Cardiovasc Surg (2004) 3.02
Effect of body mass index on early outcomes in patients undergoing coronary artery bypass surgery. J Am Coll Cardiol (2003) 2.87
Combined clopidogrel and aspirin treatment up to surgery increases the risk of postoperative myocardial infarction, blood loss and reoperation for bleeding in patients undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg (2012) 2.69
Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer. J Clin Oncol (2009) 2.48
An economic evaluation of lung transplantation. J Thorac Cardiovasc Surg (2002) 2.29
Radial versus right internal thoracic artery as a second arterial conduit for coronary surgery: early and midterm outcomes. J Thorac Cardiovasc Surg (2003) 2.29
Effect of adding postoperative noninvasive ventilation to usual care to prevent pulmonary complications in patients undergoing coronary artery bypass grafting: a randomized controlled trial. J Thorac Cardiovasc Surg (2013) 2.18
Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics (2005) 1.85
Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol (2009) 1.78
Retinal and cerebral microembolization during coronary artery bypass surgery: a randomized, controlled trial. Circulation (2005) 1.68
Pulmonary injury after cardiopulmonary bypass: beneficial effects of low-frequency mechanical ventilation. J Thorac Cardiovasc Surg (2009) 1.60
Trends in long-term mechanical circulatory support for advanced heart failure in the UK. Eur J Heart Fail (2013) 1.57
Primary care mental health and Alma-Ata: from evidence to action. Ment Health Fam Med (2008) 1.55
On-pump and off-pump coronary artery bypass grafting in patients with left main stem disease: a propensity score analysis. J Thorac Cardiovasc Surg (2011) 1.55
Evaluation of the effectiveness of off-pump coronary artery bypass grafting in high-risk patients: an observational study. Ann Thorac Surg (2002) 1.53
Role of deferiprone in chelation therapy for transfusional iron overload. Blood (2003) 1.52
Effects of preoperative statin treatment on the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. Ann Thorac Surg (2009) 1.51
A clinical score to predict the need for intraaortic balloon pump in patients undergoing coronary artery bypass grafting. Ann Thorac Surg (2010) 1.50
Interactive effects of homocysteine and copper on angiogenesis in porcine isolated saphenous vein. Ann Thorac Surg (2007) 1.48
Coronary artery bypass grafting on the beating heart: surgical revascularization for the next decade? Eur Heart J (2004) 1.48
Prevention of post-cardiopulmonary bypass acute kidney injury by endothelin A receptor blockade. Crit Care Med (2011) 1.48
Retrograde hot-shot cardioplegia in patients with left ventricular hypertrophy undergoing aortic valve replacement. Ann Thorac Surg (2008) 1.48
Phosphodiesterase-5 inhibition prevents postcardiopulmonary bypass acute kidney injury in swine. Ann Thorac Surg (2011) 1.46
Does the method of lung preservation influence outcome after transplantation? An analysis of 681 consecutive procedures. J Thorac Cardiovasc Surg (2007) 1.45
Training residents in off-pump coronary artery bypass surgery: a 14-year experience. J Thorac Cardiovasc Surg (2011) 1.44
Off-pump coronary artery bypass grafting: for the many or the few? J Thorac Cardiovasc Surg (2010) 1.42
Coronary collateral circulation: effect on early and midterm outcomes after off-pump coronary artery bypass surgery. Ann Thorac Surg (2008) 1.42
Effect of normothermic cardiopulmonary bypass on renal injury in pediatric cardiac surgery: a randomized controlled trial. J Thorac Cardiovasc Surg (2011) 1.41
Mild renal dysfunction in patients undergoing cardiac surgery as a new risk factor for EuroSCORE. Heart (2010) 1.40
Multislice computed tomography coronary angiography in patients admitted with a suspected acute coronary syndrome. Int J Cardiovasc Imaging (2006) 1.39
Saphenous vein harvest with the Mayo extraluminal dissector: is endothelial function preserved? J Thorac Cardiovasc Surg (2008) 1.39
Orally administered penicillamine is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts. J Thorac Cardiovasc Surg (2007) 1.39
Early and midterm clinical outcome in patients with severe left ventricular dysfunction undergoing coronary artery surgery. Ann Thorac Surg (2003) 1.39
Activities of moxifloxacin against, and emergence of resistance in, Streptococcus pneumoniae and Pseudomonas aeruginosa in an in vitro pharmacokinetic model. Antimicrob Agents Chemother (2003) 1.37
The cost of somatisation among the working-age population in England for the year 2008-2009. Ment Health Fam Med (2010) 1.34
Propofol is cardioprotective in a clinically relevant model of normothermic blood cardioplegic arrest and cardiopulmonary bypass. Exp Biol Med (Maywood) (2005) 1.24
Dismantling of cadherin-mediated cell-cell contacts modulates smooth muscle cell proliferation. Circ Res (2003) 1.23
Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up. Blood (2011) 1.23
Exogenous hydrogen sulfide inhibits superoxide formation, NOX-1 expression and Rac1 activity in human vascular smooth muscle cells. J Vasc Res (2008) 1.15
Does oxidative stress change ceruloplasmin from a protective to a vasculopathic factor? Atherosclerosis (2006) 1.15
Pharmacological therapies for the prevention of acute kidney injury following cardiac surgery: a systematic review. Heart Fail Rev (2011) 1.12
Myocardial protection with intermittent cold blood during aortic valve operation: antegrade versus retrograde delivery. Ann Thorac Surg (2003) 1.11
Pharmacogenetic associations with vascular endothelial growth factor inhibition in participants with neovascular age-related macular degeneration in the IVAN Study. Ophthalmology (2013) 1.11
Iloprost inhibits superoxide formation and gp91phox expression induced by the thromboxane A2 analogue U46619, 8-isoprostane F2alpha, prostaglandin F2alpha, cytokines and endotoxin in the pig pulmonary artery. Br J Pharmacol (2004) 1.10
Beating heart against cardioplegic arrest studies (BHACAS 1 and 2): quality of life at mid-term follow-up in two randomised controlled trials. Eur Heart J (2004) 1.10
R-cadherin:beta-catenin complex and its association with vascular smooth muscle cell proliferation. Arterioscler Thromb Vasc Biol (2004) 1.08
The QOF, NICE, and depression. Br J Gen Pract (2011) 1.07
Splanchnic organ injury during coronary surgery with or without cardiopulmonary bypass: a randomized, controlled trial. Ann Thorac Surg (2006) 1.06
Social networks--the future for health care delivery. Soc Sci Med (2012) 1.03
Morbidity and mortality following acute conversion from off-pump to on-pump coronary surgery. Eur J Cardiothorac Surg (2006) 1.02
Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath. J Vasc Surg (2004) 1.01
Reactive oxygen species, vascular disease and cardiovascular surgery. Curr Vasc Pharmacol (2004) 0.99
Effect of hydrogen sulphide-donating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats. BJU Int (2009) 0.98
Sildenafil citrate and sildenafil nitrate (NCX 911) are potent inhibitors of superoxide formation and gp91phox expression in porcine pulmonary artery endothelial cells. Br J Pharmacol (2005) 0.98
Off-pump coronary artery bypass grafting: not a flash in the pan. Ann Thorac Surg (2003) 0.98
Transcriptomic analysis of patients with tetralogy of Fallot reveals the effect of chronic hypoxia on myocardial gene expression. J Thorac Cardiovasc Surg (2010) 0.98
Bedside tool for predicting the risk of postoperative atrial fibrillation after cardiac surgery: the POAF score. J Am Heart Assoc (2014) 0.96
Concise review: MicroRNAs as modulators of stem cells and angiogenesis. Stem Cells (2014) 0.95
Bioaccumulation of nutrient elements from fly ash-amended soil in Jatropha curcas L.: a biofuel crop. Environ Monit Assess (2013) 0.95
Effect of sildenafil citrate and a nitric oxide donating sildenafil derivative, NCX 911, on cavernosal relaxation and superoxide formation in hypercholesterolaemic rabbits. Eur J Pharmacol (2005) 0.95
Donor cause of death and medium-term survival after heart transplantation: a United Kingdom national study. J Thorac Cardiovasc Surg (2005) 0.94
Periadventitial rapamycin-eluting microbeads promote vein graft disease in long-term pig vein-into-artery interposition grafts. Circ Cardiovasc Interv (2010) 0.93
Oxidative stress, nitric oxide, and vascular disease. J Card Surg (2003) 0.93
The effect of diabetes mellitus on patients undergoing coronary surgery: a risk-adjusted analysis. J Thorac Cardiovasc Surg (2006) 0.92
On the biology of saphenous vein grafts fitted with external synthetic sheaths and stents. Biomaterials (2006) 0.92
Superoxide auto-augments superoxide formation and upregulates gp91(phox) expression in porcine pulmonary artery endothelial cells: inhibition by iloprost. Eur J Pharmacol (2006) 0.92
An open randomized controlled trial of median sternotomy versus anterolateral left thoracotomy on morbidity and health care resource use in patients having off-pump coronary artery bypass surgery: the Sternotomy Versus Thoracotomy (STET) trial. J Thorac Cardiovasc Surg (2012) 0.92
Palivizumab use in subjects with congenital heart disease: results from the 2000-2004 Palivizumab Outcomes Registry. Pediatr Cardiol (2007) 0.91
Thoracic endovascular repair versus open surgical repair - which is the more cost-effective intervention for descending thoracic aortic pathologies? Eur J Cardiothorac Surg (2011) 0.91
Predictors of new malignant ventricular arrhythmias after coronary surgery: a case-control study. J Am Coll Cardiol (2004) 0.90
Transforming growth factor-beta is activated by plasmin and inhibits smooth muscle cell death in human saphenous vein. J Vasc Res (2005) 0.90
A randomized trial of an external Dacron sheath for the prevention of vein graft disease: the Extent study. J Thorac Cardiovasc Surg (2007) 0.90
Monitoring the performance of residents during training in off-pump coronary surgery. J Thorac Cardiovasc Surg (2004) 0.89
Off-pump coronary artery bypass surgery is associated with fewer gene expression changes in the human myocardium in comparison with on-pump surgery. Physiol Genomics (2010) 0.89
Coronary surgery in patients with preexisting chronic atrial fibrillation: early and midterm clinical outcome. Ann Thorac Surg (2006) 0.88
A bioabsorbable (polyglactin), nonrestrictive, external sheath inhibits porcine saphenous vein graft thickening. J Thorac Cardiovasc Surg (2004) 0.88
The importance of cold and warm cardiac ischemia for survival after heart transplantation. Transplantation (2008) 0.87
Off-pump coronary artery bypass surgery: the implications of the evidence. J Thorac Cardiovasc Surg (2003) 0.87
Alterations in matrix metalloproteinase-9 levels and tissue inhibitor of matrix metalloproteinases-1 expression in a transforming growth factor-beta transgenic model of hydrocephalus. J Neurosci Res (2002) 0.87